Botox Wins FDA Approval for Lower Face and Neck as EveLab Adds 3D AI Neck Scans
Updated
Updated · Harper's BAZAAR · Jun 23
Botox Wins FDA Approval for Lower Face and Neck as EveLab Adds 3D AI Neck Scans
2 articles · Updated · Harper's BAZAAR · Jun 23
Summary
Botox has now secured FDA approval for treating the lower face and neck, giving injectors a studied, standardized approach to platysma bands that had long been treated off-label.
That approval comes as demand rises for neck treatments driven by earlier visible aging, thinner collagen in the area and “tech neck” lines from repeated downward screen use.
EveLab Insight said its Eve V platform—already used by brands including Shiseido, Beiersdorf, Dior and Amorepacific—will expand from facial analysis to AI-powered neck scans for brands and doctors next year.
Newer neck options also include Ultherapy Prime, which aims to tighten skin over 2 to 3 months, and QuantumRF, which doctors say can deliver near-immediate results with about 1 day of recovery.
Doctors still frame neck care as a multimodal market rather than a single-product fix, combining topicals such as retinol with injectables, devices and at-home light therapy.